scholarly journals Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid

2012 ◽  
Vol 37 (10) ◽  
pp. 1158-1161 ◽  
Author(s):  
Sarah W. Book ◽  
Suzanne E. Thomas ◽  
Joshua P. Smith ◽  
Peter M. Miller
Author(s):  
Katharine A. Phillips

This chapter discusses assessment of body dysmorphic disorder (BDD), including diagnosis and screening as well as potential diagnostic pitfalls and how to avoid them. Measures used to screen for BDD, diagnose BDD, and assess BDD severity and BDD-related insight are reviewed, and guidelines for their use are provided. This chapter also discusses assessment of BDD in children and adolescents and assessment of patients who seek cosmetic procedures (such as surgery or dermatologic treatment) for appearance concerns. Because BDD is common, often severe, and usually missed in clinical settings, clinicians and researchers should routinely screen for BDD. Screening is especially recommended in mental health, substance abuse, dermatology, cosmetic surgery, and other cosmetic treatment settings. It is also important to screen for BDD when patients manifest clues suggesting a possible diagnosis of BDD (e.g., BDD rituals, camouflaging of disliked body areas, and social anxiety or avoidance).


Author(s):  
Tami L. Mark ◽  
William N. Dowd ◽  
Carol L. Council

The objective of this study was to track trends in the signs of higher-quality addiction treatment as defined by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Addiction, and the Substance Abuse and Mental Health Services Administration. We analyzed the National Survey of Substance Abuse Treatment Services from 2007 through 2017 to determine the percent of facilities having the characteristics of higher quality. We analyzed the percent by state and over time. • We found improvements between 2007 and 2017 on most measures, but performance on several measures remained low. • Most programs reported providing evidence-based behavioral therapies. • Half or fewer facilities offered medications for opioid use disorder; mental health assessments; testing for hepatitis C, HIV, and sexually transmitted diseases; self-help groups; employment assistance; and transportation assistance. • There was significant state-level variation across the measures.


Sign in / Sign up

Export Citation Format

Share Document